StockNews.com initiated coverage on shares of Organovo (NASDAQ:ONVO – Free Report) in a research report report published on Monday. The brokerage issued a sell rating on the medical research company’s ...
Among significant research news last week, US CNS specialist Axsome Therapeutics released new Phase III data on its recently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback